FDA's Proposed Changes to Generic Drug Label Rules Questioned by Members of Congress
Health Reform Watch, January 2014
2 Pages Posted: 3 Apr 2014
Date Written: January 29, 2014
This blog entry discusses the FDA's proposed regulation published in November 2013 that would allow generic drug manufacturers to make labeling changes in the wake of Mutual Pharmaceuticals v. Bartlett and Pliva v. Mensing.
Keywords: generic drugs, labeling, proposed regulation, FDA, Supreme Court
Suggested Citation: Suggested Citation